Curcuma longa has been mentioned in Indian system of medicine for the management of wide range of diseases.
C. longa and its metabolites like curcumin, ar-turmerone, methyl-curcumin, demethoxy-curcumin, bisdemethoxy-curcumin
have also been reported beneficial in various types of cancer. Curcumin elicits anticancer properties chiefly by triggering
apoptotic pathways in cancer cells. The properties are facilitated through diverse signaling pathways viz. pathways mediated
by NF-kB, WNT/β-catenin pathway COX-2, LOX, STAT3, prostaglandin E2, phosphorylase kinase, VEGF, AKT, AP1,
STAT3, PI3K, Akt, mTOR, ERK5, AP-1, TGF-b, PPARc, EBPa, NLRP3 inflammasome, p38MAPK, Nrf2, Notch-1,
AMPK, TLR-4 etc. Present article highlights curcumin biosynthesis, phytochemistry and diverse molecular pathways
involved to regulate several types of secondary messengers to exhibit anticancer activity in almost all the forms of cancer.